Candida albicans is a major pathogen in the immunocompromised individual. Since acquired immune mechanisms in the normal individual are poorly understood, management of the immunocompromised individual is often empirical. Further, individuals with serious candidal disease often have circulating antigen; its effect on the immune system is poorly understood. The major objectives of this research, therefore, are to define the lymphocyte classes involved 1) in acquired immunity to C. albicans, and 2) in immunomodulation induced by circulating Candida antigen. All experiments will be done in a murine model of experimental candidiasis. Two approaches will be taken to investigate the first objective, 1) transfer of lymphoid cells from immunized donors to naive recipients, and 2) anti-mu suppression of mice. Populations of T, B or T-subset lymphocytes, isolated by panning or prepared by cytotoxic antibody depletion, will be obtained from animals immunized by cutaneous inoculation of viable C. albicans. Following transfer, recipients will be challenged intravenously with viable C. albicans and organs will be cultured after a suitable interval to assess protection. To assess the role of antibody in a protective response, animals will be suppressed by inoculation of anti-mu from birth, then as adults, they will be immunized and immune responses measured, including resistance to systemic challenge. Transfers of Candida-specific antibody into anti-mu treated mice may be done also. Since mannan extracted from C. albicans can be separated by ion- exchange chromatography into components which have either enhancing or suppressing effects on antibody responses to type III pneumococcal polysaccharide (SSS-III), a T helper cell- independent antigen, and sheep erythrocytes (SRBC), a T helper cell-dependent antigen, the cellular targets for the regulatory phenomena will be studied. Splenic antibody-forming cells will be quantitated by plaque assay, following transfers of lymphoid populations from immunized and mannan-treated donors into naive recipients. Studies to determine possible immunoregulation by mannan on delayed hypersensitivity (DTH) will involve giving mannan to mice at various times with respect to immunization with SRBC followed by assessment of DTH in vivo by footpad testing. If time permits, investigations of interleukins and gamma interferon as potential mediators of the regulatory phenomena observed will be begun.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI012806-12
Application #
3125302
Study Section
Bacteriology and Mycology Subcommittee 1 (BM)
Project Start
1978-07-01
Project End
1990-11-30
Budget Start
1988-12-01
Budget End
1990-11-30
Support Year
12
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Tulane University
Department
Type
Schools of Medicine
DUNS #
City
New Orleans
State
LA
Country
United States
Zip Code
70118
Cardenas-Freytag, L; Cheng, E; Mirza, A (1999) New approaches to mucosal immunization. Adv Exp Med Biol 473:319-37
Cardenas-Freytag, L; Cheng, E; Mayeux, P et al. (1999) Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis. Infect Immun 67:826-33
Wang, Y; Li, S P; Moser, S A et al. (1998) Cytokine involvement in immunomodulatory activity affected by Candida albicans mannan. Infect Immun 66:1384-91
Li, S P; Lee, S I; Domer, J E (1998) Alterations in frequency of interleukin-2 (IL-2)-, gamma interferon-, or IL-4-secreting splenocytes induced by Candida albicans mannan and/or monophosphoryl lipid A. Infect Immun 66:1392-9
Domer, J E; Asherson, G L; Li, S (1996) Treatment of Candida albicans mannan-specific downregulatory cell populations with divergent concentrations of monophosphoryl lipid A and intact lipopolysaccharide in vitro abrogates their effect on delayed hypersensitivity. Cell Immunol 167:8-17
Li, S P; Lee, S I; Wang, Y et al. (1996) Candida albicans mannan-specific, delayed hypersensitivity down-regulatory CD8+ cells are genetically restricted effectors and their production requires CD4 and I-A expression. Int Arch Allergy Immunol 109:334-43
Mayeux, P; Dupepe, L; Dunn, K et al. (1995) Massive fungal contamination in animal care facilities traced to bedding supply. Appl Environ Microbiol 61:2297-301
Stevens, D A; Domer, J E; Ashman, R B et al. (1994) Immunomodulation in mycoses. J Med Vet Mycol 32 Suppl 1:253-65
Garner, R E; Domer, J E (1994) Lack of effect of Candida albicans mannan on development of protective immune responses in experimental murine candidiasis. Infect Immun 62:738-41
Domer, J E; Human, L G; Andersen, G B et al. (1993) Abrogation of suppression of delayed hypersensitivity induced by Candida albicans-derived mannan by treatment with monophosphoryl lipid A. Infect Immun 61:2122-30

Showing the most recent 10 out of 18 publications